Literature DB >> 25843408

Melatonin affects voltage-dependent calcium and potassium currents in MCF-7 cell line cultured either in growth or differentiation medium.

Roberta Squecco1, Alessia Tani2, Sandra Zecchi-Orlandini1, Lucia Formigli2, Fabio Francini3.   

Abstract

Big efforts have been dedicated up to now to identify novel targets for cancer treatment. The peculiar biophysical profile and the atypical ionic channels activity shown by diverse types of human cancers suggest that ion channels may be possible targets in cancer therapy. Earlier studies have shown that melatonin exerts an oncostatic action on different tumors. In particular, it was shown that melatonin was able to inhibit growth/viability and proliferation, to reduce the invasiveness and metastatic properties of human estrogen-sensitive breast adenocarcinoma MCF-7 cell line cultured in growth medium, with substantial impairments of epidermal growth factor (EGF) and Notch-1-mediated signaling. The purpose of this work was to evaluate on MCF-7 cells the possible effects of melatonin on the biophysical features known to have a role in proliferation and differentiation, by using the patch-clamp technique. Our results show that in cells cultured in growth as well as in differentiation medium melatonin caused a hyperpolarization of resting membrane potential paralleled by significant changes of the inward Ca(2+) currents (T- and L-type), outward delayed rectifier K(+) currents and cell capacitance. All these effects are involved in MCF-7 growth and differentiation. These findings strongly suggest that melatonin, acting as a modulator of different voltage-dependent ion channels, might be considered a new promising tool for specifically disrupting cell viability and differentiation pathways in tumour cells with possible beneficial effects on cancer therapy.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chromanol (PubChem CID: 92890); Electrophysiology; Iberiotoxin (PubChem CID: 16132435); Melatonin; Melatonin (PubChem CID: 896); Nifedipine (PubChem CID: 4485); Voltage-dependent Ca(2+) currents; Voltage-dependent K(+) currents; α-Dendrotoxin (PubChem SID: 135651983)

Mesh:

Substances:

Year:  2015        PMID: 25843408     DOI: 10.1016/j.ejphar.2015.03.068

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

Review 1.  Targeting Ion Channels for Cancer Treatment: Current Progress and Future Challenges.

Authors:  Alina L Capatina; Dimitris Lagos; William J Brackenbury
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

2.  Application of a validated HPLC-PDA method for the determination of melatonin content and its release from poly(lactic acid) nanoparticles.

Authors:  Leiziani Gnatkowski Martins; Najeh Maissar Khalil; Rubiana Mara Mainardes
Journal:  J Pharm Anal       Date:  2017-05-20

3.  Calcium acts as a central player in melatonin antitumor activity in sarcoma cells.

Authors:  Ana M Sánchez-Sánchez; María Turos-Cabal; Noelia Puente-Moncada; Federico Herrera; Carmen Rodríguez; Vanesa Martín
Journal:  Cell Oncol (Dordr)       Date:  2022-05-02       Impact factor: 7.051

Review 4.  Store-Independent Calcium Entry and Related Signaling Pathways in Breast Cancer.

Authors:  Mohamed Chamlali; Lise Rodat-Despoix; Halima Ouadid-Ahidouch
Journal:  Genes (Basel)       Date:  2021-06-29       Impact factor: 4.096

Review 5.  CaV channels and cancer: canonical functions indicate benefits of repurposed drugs as cancer therapeutics.

Authors:  Paul J Buchanan; Karen D McCloskey
Journal:  Eur Biophys J       Date:  2016-06-24       Impact factor: 1.733

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.